You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 7, July 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Cerebrovascular Disease
 •Cognitive Disorders
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Hypertension and Mild Cognitive Impairment Subtypes

Francesco Panza, MD, PhD; Cristiano Capurso, MD, PhD; Alessia D’Introno, PhD; Anna M. Colacicco, PhD; Andrea Santamato, MD; Antonio Capurso, MD; Vincenzo Solfrizzi, MD, PhD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Reitz et al1 reported the results of a very interesting longitudinal community-based study involving 918 older persons in northern Manhattan in which hypertension was associated with an increased risk of all-cause mild cognitive impairment (MCI) and nonamnestic MCI (NAMCI) after adjusting for age and sex. These associations were not significant after adjusting for sex, age, ethnic group, years of education, apolipoprotein E (APOE) genotype, stroke, diabetes mellitus, heart disease, current smoking, and low-density lipoprotein cholesterol level. There was no relation between hypertension history and the risk of incident amnestic MCI (AMCI), and there was no effect modification of the association between hypertension and any MCI subtype by APOE{varepsilon}4 genotype or use of antihypertensive medication. Reitz and colleagues described these results as consistent . . . [Full Text of this Article]

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Hypertension and the Risk of Mild Cognitive Impairment
Christiane Reitz, Ming-Xin Tang, Jennifer Manly, Richard Mayeux, and José A. Luchsinger
Arch Neurol. 2007;64(12):1734-1740.
ABSTRACT | FULL TEXT  

Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study: Part 2
Oscar L. Lopez, William J. Jagust, Corinne Dulberg, James T. Becker, Steven T. DeKosky, Annette Fitzpatrick, John Breitner, Constantine Lyketsos, Beverly Jones, Claudia Kawas, Michelle Carlson, and Lewis H. Kuller
Arch Neurol. 2003;60(10):1394-1399.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.